HSBC Holdings’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.71B Sell
1,865,688
-118,868
-6% -$121M 0.9% 14
2025
Q4
$2.13B Buy
1,984,556
+95,172
+5% +$91M 1.09% 12
2025
Q3
$1.43B Sell
1,889,384
-105,881
-5% -$78.8M 0.79% 16
2025
Q2
$1.55B Sell
1,995,265
-137,921
-6% -$107M 0.93% 14
2025
Q1
$1.76B Buy
2,133,186
+51,076
+2% +$42.5M 1.08% 13
2024
Q4
$1.61B Sell
2,082,110
-70,987
-3% -$58.8M 0.93% 13
2024
Q3
$1.9B Sell
2,153,097
-126,699
-6% -$114M 1.11% 10
2024
Q2
$2.07B Buy
2,279,796
+93,977
+4% +$75.2M 1.26% 9
2024
Q1
$1.7B Buy
2,185,819
+437,166
+25% +$311M 1.15% 9
2023
Q4
$1.02B Buy
1,748,653
+238,660
+16% +$139M 0.89% 16
2023
Q3
$810M Buy
1,509,993
+130,779
+9% +$67.4M 0.84% 15
2023
Q2
$647M Buy
1,379,214
+118,428
+9% +$49.7M 0.66% 23
2023
Q1
$433M Sell
1,260,786
-113,869
-8% -$38.4M 0.52% 30
2022
Q4
$502M Buy
1,374,655
+494,047
+56% +$175M 0.58% 24
2022
Q3
$288M Sell
880,608
-178,999
-17% -$56.7M 0.47% 30
2022
Q2
$344M Buy
1,059,607
+146,946
+16% +$44.1M 0.48% 33
2022
Q1
$263M Sell
912,661
-49,870
-5% -$12.8M 0.32% 47
2021
Q4
$267M Sell
962,531
-92,576
-9% -$23.5M 0.25% 64
2021
Q3
$244M Sell
1,055,107
-11,538
-1% -$2.85M 0.25% 66
2021
Q2
$245M Sell
1,066,645
-76,068
-7% -$15.3M 0.26% 65
2021
Q1
$213M Sell
1,142,713
-70,151
-6% -$13.7M 0.25% 81
2020
Q4
$204M Buy
1,212,864
+137,224
+13% +$20.5M 0.27% 66
2020
Q3
$159M Buy
1,075,640
+214,009
+25% +$33.1M 0.25% 66
2020
Q2
$141M Sell
861,631
-86,175
-9% -$13.2M 0.27% 67
2020
Q1
$131M Sell
947,806
-43,078
-4% -$5.92M 0.31% 58
2019
Q4
$131M Buy
990,884
+101,577
+11% +$11.8M 0.23% 79
2019
Q3
$99.5M Sell
889,307
-10,539
-1% -$1.17M 0.19% 101
2019
Q2
$99.7M Buy
899,846
+62,334
+7% +$7.34M 0.19% 107
2019
Q1
$109M Sell
837,512
-74,701
-8% -$9.08M 0.2% 109
2018
Q4
$105M Sell
912,213
-246,145
-21% -$27.5M 0.19% 99
2018
Q3
$124M Sell
1,158,358
-90,602
-7% -$9.06M 0.2% 93
2018
Q2
$107M Sell
1,248,960
-850,181
-41% -$69.8M 0.19% 93
2018
Q1
$162M Buy
2,099,141
+7,395
+0.4% +$595K 0.24% 71
2017
Q4
$177M Buy
2,091,746
+252,743
+14% +$21.5M 0.26% 74
2017
Q3
$157M Buy
1,839,003
+294,233
+19% +$24.1M 0.25% 72
2017
Q2
$127M Buy
1,544,770
+594,327
+63% +$48.5M 0.23% 70
2017
Q1
$80.1M Sell
950,443
-262,570
-22% -$21M 0.17% 108
2016
Q4
$89.2M Buy
1,213,013
+99,944
+9% +$7.44M 0.21% 96
2016
Q3
$89.3M Buy
1,113,069
+199,955
+22% +$16M 0.22% 96
2016
Q2
$71.9M Sell
913,114
-196,259
-18% -$14.8M 0.2% 111
2016
Q1
$79.9M Sell
1,109,373
-247,616
-18% -$18.7M 0.23% 96
2015
Q4
$115M Buy
1,356,989
+276,369
+26% +$22.9M 0.28% 69
2015
Q3
$90.1M Buy
1,080,620
+299,198
+38% +$25.3M 0.23% 92
2015
Q2
$65.3M Sell
781,422
-682,433
-47% -$52M 0.13% 174
2015
Q1
$106M Buy
1,463,855
+19,793
+1% +$1.41M 0.2% 103
2014
Q4
$99.7M Sell
1,444,062
-115,333
-7% -$7.78M 0.21% 103
2014
Q3
$101M Sell
1,559,395
-1,420,591
-48% -$89.9M 0.21% 98
2014
Q2
$186M Sell
2,979,986
-593
-0% -$35.4K 0.4% 53
2014
Q1
$175M Buy
2,980,579
+1,428,582
+92% +$79.7M 0.42% 51
2013
Q4
$79.2M Sell
1,551,997
-104,682
-6% -$5.24M 0.21% 103
2013
Q3
$83.4M Sell
1,656,679
-1,182,882
-42% -$61.9M 0.23% 100
2013
Q2
$140M Buy
+2,839,561
New +$155M 0.42% 50

Other funds holding LLY

HSBC Holdings's LLY Position: Q1 2026 in Review

HSBC Holdings reduced its Eli Lilly (LLY) stake by 6% in Q1 2026, selling an estimated $121M and leaving 1,865,688 shares worth $1.71B. The position accounts for 0.9% of the portfolio, ranked #14.

HSBC Holdings first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.13B in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • HSBC Holdings held 1,865,688 shares of Eli Lilly worth $1.71B as of Q1 2026.
  • HSBC Holdings sold 118,868 Eli Lilly shares in Q1 2026, an estimated $121M.
  • Eli Lilly made up 0.9% of HSBC Holdings's portfolio in Q1 2026, its #14 holding.
  • HSBC Holdings first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • HSBC Holdings's Eli Lilly position peaked at $2.13B in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.